These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Johnson SR; Mehta S; Granton JT Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918 [TBL] [Abstract][Full Text] [Related]
4. Can anticoagulants improve the survival rate for patients with idiopathic pulmonary arterial hypertension? A systematic review and meta-analysis. Wang P; Hu L; Yin Y; Yan D; Zheng H; Zhang J; Li Y Thromb Res; 2020 Dec; 196():251-256. PubMed ID: 32920295 [TBL] [Abstract][Full Text] [Related]
5. Survival benefits of oral anticoagulants in patients with pulmonary arterial hypertension: Protocol for a systematic review and meta-analysis. Zhang HC; Wang N; Zhang W; Gu ZC; Liu XY Medicine (Baltimore); 2018 Sep; 97(36):e12203. PubMed ID: 30200129 [TBL] [Abstract][Full Text] [Related]
6. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge. Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the quality of anticoagulation management in patients with pulmonary arterial hypertension. Roldan T; Villamañán E; Rios JJ; Waxman AB Thromb Res; 2017 Dec; 160():83-90. PubMed ID: 29127864 [TBL] [Abstract][Full Text] [Related]
11. Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study. Goudie A; Elder D; Deshmukh H; Szwejkowski BR; Lang CC; George J Eur J Heart Fail; 2015 Jan; 17(1):90-7. PubMed ID: 25427720 [TBL] [Abstract][Full Text] [Related]
12. The complicated question of anticoagulation in pulmonary arterial hypertension: time to get some simple answers. Hatton N; Ryan JJ Can J Cardiol; 2014 Aug; 30(8):850-2. PubMed ID: 24986047 [No Abstract] [Full Text] [Related]
13. Anticoagulation in Pulmonary Arterial Hypertension. Robinson JC; Pugliese SC; Fox DL; Badesch DB Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522 [TBL] [Abstract][Full Text] [Related]
14. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil. Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628 [TBL] [Abstract][Full Text] [Related]
16. Should patients with systemic sclerosis-related pulmonary arterial hypertension be anticoagulated? Nikpour M; Stevens W; Proudman SM; Buchbinder R; Prior D; Zochling J; Williams T; Gabbay E; Nandurkar H Intern Med J; 2013 May; 43(5):599-603. PubMed ID: 23668273 [TBL] [Abstract][Full Text] [Related]
17. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis. Van Der Meersch H; De Bacquer D; De Vriese AS Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885 [TBL] [Abstract][Full Text] [Related]
18. Effects of oral treatments on clinical outcomes in pulmonary arterial hypertension: A systematic review and meta-analysis. Zhang HD; Zhang R; Jiang X; Sun K; Wu DC; Jing ZC Am Heart J; 2015 Jul; 170(1):96-103, 103.e1-14. PubMed ID: 26093869 [TBL] [Abstract][Full Text] [Related]
19. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Johnson SR; Granton JT; Mehta S Chest; 2006 Aug; 130(2):545-52. PubMed ID: 16899857 [TBL] [Abstract][Full Text] [Related]
20. Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer? Rawal H; Suman A; Bhoite RR; Kanwal A; Young RK; Aronow WS; Lavie C; Ghosh RK Curr Probl Cardiol; 2021 Mar; 46(3):100738. PubMed ID: 33250263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]